Poulin, Yves
Centre de Recherche Dermatologique du Québec Métropolitain · Université Laval
7 papers on CoChatORCID 0000-0003-0383-0870
Most cited papers
- Verified
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine
Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis
Cited by 2,110
- Verified
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*
Wollenberg, A., Blauvelt, A., Guttman‐Yassky, E., Worm, M., Lynde, C., Lacour, J. ‐., Spelman, L., Katoh, N., Saeki, H., Poulin, Y., et al. (2021) · British Journal of Dermatology
Dermatology and Skin DiseasesAsthma and respiratory diseases
Cited by 638
- Verified
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
Silverberg, J. I., Pinter, A., Pulka, G., Poulin, Y., Bouaziz, J.-D., Wollenberg, A., Murrell, D. F., Alexis, A., Lindsey, L., Ahmad, F., et al. (2020) · Journal of Allergy and Clinical Immunology
Dermatology and Skin DiseasesAsthma and respiratory diseases
Cited by 271
- Verified
A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis
Simpson, E. L., Imafuku, S., Poulin, Y., Ungar, B., Zhou, L., Malik, K., Wen, H.-C., Xu, H., Estrada, Y. D., Peng, X., et al. (2019) · Journal of Investigative Dermatology
Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis
Cited by 120
- Verified
Management of acne: Canadian clinical practice guideline
Asai, Y., Baibergenova, A., Dutil, M., Humphrey, S., Hull, P., Lynde, C., Poulin, Y., Shear, N. H., Tan, J., Toole, J., et al. (2016) · Canadian Medical Association Journal
Acne and Rosacea Treatments and EffectsClinical practice guidelines implementation
Cited by 95
- Verified
Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial: WBI-1001 as a novel topical treatment for atopic dermatitis
Bissonnette, R., Poulin, Y., Zhou, Y., Tan, J., Hong, H. C., Webster, J., Ip, W., Tang, L., & Lyle, M. (2012) · British Journal of Dermatology
Dermatology and Skin DiseasesContact Dermatitis and Allergies
Cited by 92
- Verified
Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial
Thiboutot, D., Pariser, D. M., Egan, N., Flores, J., Herndon, J. H., Kanof, N. B., Kempers, S. E., Maddin, S., Poulin, Y. P., Wilson, D. C., et al. (2006) · Journal of the American Academy of Dermatology
Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases
Cited by 67
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free